Standout Papers

Oncogenic pathway signatures in human cancers as a guide to targeted therapies... 2001 2026 2009 2017 1.5k
  1. Oncogenic pathway signatures in human cancers as a guide to targeted therapies (2005)
    Andrea Bild, Guang Yao et al. Nature
  2. Predicting the clinical status of human breast cancer by using gene expression profiles (2001)
    Mike West, Carrie Blanchette et al. Proceedings of the National Academy of Sciences
  3. Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression (2008)
    Carey K. Anders, David S. Hsu et al. Journal of Clinical Oncology

Immediate Impact

13 by Nobel laureates 23 from Science/Nature 67 standout
Sub-graph 1 of 18

Citing Papers

Sublethal cytochrome c release generates drug-tolerant persister cells
2022 Standout
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020 Standout

Works of Jeffrey R. Marks being referenced

The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
2011
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature

Author Peers

Author Last Decade Papers Cites
Jeffrey R. Marks 9076 5523 4582 212 15.8k
Elise C. Kohn 11353 6592 4014 324 20.4k
James D. Brenton 5812 3931 6054 163 12.2k
Bryan T. Hennessy 9505 8714 6232 259 19.1k
Samuel Leung 5137 6486 6832 118 15.0k
Åke Borg 10142 6824 6729 275 18.3k
Britta Weigelt 7666 7897 8261 304 18.6k
Jan G.M. Klijn 6576 6032 5873 148 16.5k
Laura van ‘t Veer 7608 4995 5767 200 14.1k
J. Dirk Iglehart 5439 4788 3115 138 10.6k
Xavier Matías‐Guiu 6212 4092 3460 431 15.6k

All Works

Loading papers...

Rankless by CCL
2026